Selected Publications
Vivek Narayan, Julie S. Barber-Rotenberg, In-Young Jung, Simon F. Lacey, Andrew J. Rech, Megan M. Davis, Wei-Ting Hwang, Priti Lal, Erica L. Carpenter, Shannon L. Maude, Gabriela Plesa, Neha Vapiwala, Anne Chew, Michael Moniak, Ronnie A. Sebro, Michael D. Farwell, Amy Marshall, Joan Gilmore, Lester Lledo, Karen Dengel, Sarah E. Church, Tyler D. Hether, Jun Xu, Mercy Gohil, Thomas H. Buckingham, Stephanie S. Yee, Vanessa E. Gonzalez, Irina Kulikovskaya, Fang Chen, Lifeng Tian, Kyle Tien, Whitney Gladney, Christopher L. Nobles, Hayley E. Raymond, Prostate Cancer Cellular Therapy Program Investigators, Elizabeth O. Hexner, Donald L. Siegel, Frederic D. Bushman, Carl H. June, Joseph A. Fraietta & Naomi B. Haas: PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial Nature Medicine 4 (28): 724-734,2022.
Yamoah K, Johnson MH, Choeurng V, Faisal FA, Yousefi K, Haddad Z, Ross AE, Alshalafa M, Den R, Lal Priti, Feldman M, Dicker AP, Klein EA, Davicioni E, Rebbeck TR, Schaeffer EM: Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer J Clin Oncol 33 (25): 2789-96,2015.
Vaughn DJ, Hwang WT, Lal Priti, Rosen MA, Gallagher M, O'Dwyer PJ: Phase 2 trial of the cyclin-dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors Cancer 121 (9): 1463-8,2015.
Garg R, Blando JM, Perez CJ, Lal Priti, Feldman MD, Smyth EM, Ricciotti E, Grosser T, Benavides F, Kazanietz MG: COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer Oncogene 37 (34): 4735-4749,2018.
Bhargava HK, Leo P, Elliott R, Janowczyk A, Whitney J, Gupta S, Fu P, Yamoah K, Khani F, Robinson BD, Rebbeck TR, Feldman M, Lal Priti, Madabhushi A: Computationally derived image signature of stromal morphology is prognostic of prostate cancer recurrence following prostatectomy in African American patients Clin Cancer Res 26 (8): 1915-1923,2020.
Rasool RU, Natesan R, Deng Q, Aras S, Lal Priti, Sander Effron S, Mitchell-Velasquez E, Posimo JM, Carskadon S, Baca SC, Pomerantz MM, Siddiqui J, Schwartz LE, Lee DJ, Palanisamy N, Narla G, Den RB, Freedman ML, Brady DC, Asangani IA: CDK7 inhibition suppresses Castration- Resistant Prostate Cancer through MED1 inactivaion Cancer Discov 9 (11): 1538-1555,2019.
Arriola AGP, Farahani SJ, Bhargava HK, Guzzo TJ, Brooks JSJ, Lal Priti: PDL-1 Expression reveals significant association with squamous differentiation in Upper Tract Urothelial Carcinoma Am J Clin Pathol 151 (6): 561-573,2019 .
Sadigh S, Farahani SJ, Shah A, Vaughn D, Lal Priti: Differences in PD-L1 Expressing Macrophages and Immune Micro-environment in Testicular Germ Cell Tumors Am J Clin Pathol 153 (3): 387-395,2020.
Vivek Narayan, Whitney Gladney, Gabriela Plesa, Neha Vapiwala, Erica Carpenter, Shannon L. Maude, Priti Lal, Simon F. Lacey, Jan Joseph Melenhorst, Ronnie Sebro, Michael Farwell, Wei-Ting Hwang, Michael Moniak, Joan Gilmore, Lester Lledo, Karen Dengel, Amy Marshall, Christina Marie Coughlin, Carl H. June, Naomi B. Haas: A Phase 1 Clinical Trial of PSMA-directed/TGFβ-insensitive CAR-T cells in Metastatic Castration-Resistant Prostate Cancer Am Soc of Clin Onc 2020. J of Clin Onc : 2020.
Facciabene A, Peng X, Ian SH, Barchetti A, Balint K, Wang LP, Gilks CB, Lal Priti, Zhang L, Coukos G: Tumor Hypoxia Recruits Regulatory T Cells via the CCL28 Chemokine to Promote Immune Tolerance and Angiogenesis Nature 475 (7355): 226-230,2011.
View all publications
Academic Contact Information
Department of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania
6 Founders Pavilion
3400 Spruce Street
Philadelphia,
PA
19104-4283
Phone: 215-662-6503